In combo studies for the optimization of 5-aminoanthranilic acid derivatives as potential multitarget drugs for the management of metabolic syndrome

HIGHLIGHTS

  • who: Edwin Chu00e1vez-Gutiu00e9rrez et al. from the Design, Isolation and Synthesis of Bioactive Molecules Research Group, Universidad La Salle-Mu00e9xico, Benjamu00edn Franklin, Mexico City, Mexico have published the Article: In Combo Studies for the Optimization of 5-Aminoanthranilic Acid Derivatives as Potential Multitarget Drugs for the Management of Metabolic Syndrome, in the Journal: Pharmaceuticals 2022, 1461 of 30/08/2017
  • what: This approach has drawbacks that could lead to therapeutic failure. The authors report the synthesis and in combo evaluation of new of anthranilic intending to identify the primary structural factors that improve the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?